Icon

CUVPOSA (nda022571)- (1MG/5ML)

GLYCOPYRROLATE MERZ PHARMS
1MG/5ML
Yes No
2023-Aug-20 Expired
2017-Jul-28 2013-Jul-28
None No
CUVPOSA is an anticholinergic indicated to reduce chronic severe drooling in patients aged 3-16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy).
6 0 4
Total Other Developers 13
Drugs with Suitability No
1MG/5ML ** ** Up - 3
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** ***** *************** ******* *** *********** **** ***. *** ** ***, *** ************, **********, ********* ******, ***** (***) ***
****** ***** ****** ***** *************** ******* *********** **** ***. *** ** ***, *** ************, **********, ********* ******, ***** (***) ***
****** ****** ****** ****** ****** ******* ******* *********** ****** **. ***, ******* *******, *********** ******,, **********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.